Bernard Nunes de Almeida Orr

Dr. Bernard Nunes de Almeida Orr

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2009 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
MLMariana Lince-Faria
Mariana Lince-Faria
SMStefano Maffini
Stefano Maffini
BOBernard Nunes de Almeida Orr
Bernard Nunes de Almeida Orr
YDYun Ding
Yun Ding
CFCláudia Florindo
Cláudia Florindo
HMHelder Maiato
Helder Maiato
A putative spindle matrix has been hypothesized to mediate chromosome motion, but its existence and functionality remain controversial. In this report, we show that Megator (Mtor), the Drosophilamelanogaster counterpart of the human nuclear pore complex protein translocated promoter region (Tpr), and the spindle assembly checkpoint (SAC) protein Mad2 form a conserved complex that localizes to a nuclear derived spindle matrix in living cells. Fluorescence recovery after photobleaching experiments supports that Mtor is retained around spindle microtubules, where it shows distinct dynamic properties. Mtor/Tpr promotes the recruitment of Mad2 and Mps1 but not Mad1 to unattached kinetochores (KTs), mediating normal mitotic duration and SAC response. At anaphase, Mtor plays a role in spindle elongation, thereby affecting normal chromosome movement. We propose that Mtor/Tpr functions as a spatial regulator of the SAC, which ensures the efficient recruitment of Mad2 to unattached KTs at the onset of mitosis and proper spindle maturation, whereas enrichment of Mad2 in a spindle matrix helps confine the action of a diffusible “wait anaphase” signal to the vicinity of the spindle.

1 June 2015 in Current Biology
Verified
Journal Article
Closed access
BOBernard Nunes de Almeida Orr
Bernard Nunes de Almeida Orr
KGKristina M. Godek
Kristina M. Godek
DCDuane Compton
Duane Compton

12 February 2016 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
JKJung-Sik Kim
Jung-Sik Kim
XHXiaoyuan He
Xiaoyuan He
BOBernard Nunes de Almeida Orr
Bernard Nunes de Almeida Orr
GWGordana Wutz
Gordana Wutz
VHVictoria Hill
Victoria Hill
TWTodd Waldman
Todd Waldman
Somatic mutations of the cohesin complex subunit STAG2 are present in diverse tumor types. We and others have shown that STAG2 inactivation can lead to loss of sister chromatid cohesion and alterations in chromosome copy number in experimental systems. However, studies of naturally occurring human tumors have demonstrated little, if any, correlation between STAG2 mutational status and aneuploidy, and have further shown that STAG2-deficient tumors are often euploid. In an effort to provide insight into these discrepancies, here we analyze the effect of tumor-derived STAG2 mutations on the protein composition of cohesin and the expected mitotic phenotypes of STAG2 mutation. We find that many mutant STAG2 proteins retain their ability to interact with cohesin; however, the presence of mutant STAG2 resulted in a reduction in the ability of regulatory subunits WAPL, PDS5A, and PDS5B to interact with the core cohesin ring. Using AAV-mediated gene targeting, we then introduced nine tumor-derived mutations into the endogenous allele of STAG2 in cultured human cells. While all nonsense mutations led to defects in sister chromatid cohesion and a subset induced anaphase defects, missense mutations behaved like wild-type in these assays. Furthermore, only one of nine tumor-derived mutations tested induced overt alterations in chromosome counts. These data indicate that not all tumor-derived STAG2 mutations confer defects in cohesion, chromosome segregation, and ploidy, suggesting that there are likely to be other functional effects of STAG2 inactivation in human cancer cells that are relevant to cancer pathogenesis. Mutations of the STAG2 gene are common in several types of adult and pediatric cancers. In fact, STAG2 is one of only 12 genes known to be significantly mutated in four of more types of cancer. The STAG2 gene encodes a protein component of the “cohesin complex,” a ring-like structure that binds chromosomes together (e.g., “coheres” them) until the cohesin complex is degraded during cell division, allowing replicated chromosomes to separate normally to the two new cells. The cohesin complex also plays important roles in other cellular processes including turning genes on and off, and in repairing damaged genes. Here we analyze the effect of cancer-causing mutations in STAG2 on its ability regulate the separation of chromosomes during cell division.

1 January 2013 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
BOBernard Nunes de Almeida Orr
Bernard Nunes de Almeida Orr
DCDuane A. Compton
Duane A. Compton
Most solid tumors are characterized by abnormal chromosome numbers (aneuploidy) and karyotypic profiling has shown that the majority of these tumors are heterogeneous and chromosomally unstable. Chromosomal instability (CIN) is defined as persistent mis-segregation of whole chromosomes and is caused by defects during mitosis. Large-scale genome sequencing has failed to reveal frequent mutations of genes encoding proteins involved in mitosis. On the contrary, sequencing has revealed that most mutated genes in cancer fall into a limited number of core oncogenic signaling pathways that regulate the cell cycle, cell growth, and apoptosis. This led to the notion that the induction of oncogenic signaling is a separate event from the loss of mitotic fidelity, but a growing body of evidence suggests that oncogenic signaling can deregulate cell cycle progression, growth, and differentiation as well as cause CIN. These new results indicate that the induction of CIN can no longer be considered separately from the cancer-associated driver mutations. Here we review the primary causes of CIN in mitosis and discuss how the oncogenic activation of key signal transduction pathways contributes to the induction of CIN.

9 November 2021 in Cell Reports
Verified
Journal Article
Open access
BOBernard Nunes de Almeida Orr
Bernard Nunes de Almeida Orr
FSFilipe De Sousa
Filipe De Sousa
AGAna Margarida Gomes
Ana Margarida Gomes
OAOlga Afonso
Olga Afonso
LFLuísa T. Ferreira
Luísa T. Ferreira
HMHelder Maiato
Helder Maiato
Micronuclei are a hallmark of cancer and several other human disorders. Recently, micronuclei were implicated in chromothripsis, a series of massive genomic rearrangements that may drive tumor evolution and progression. Here, we show that Aurora B kinase mediates a surveillance mechanism that integrates error correction during anaphase with spatial control of nuclear envelope reassembly to prevent micronuclei formation. Using high-resolution live-cell imaging of human cancer and non-cancer cells, we uncover that anaphase lagging chromosomes are more frequent than previously anticipated, yet they rarely form micronuclei. Micronuclei formation from anaphase lagging chromosomes is prevented by a midzone-based Aurora B phosphorylation gradient that stabilizes kinetochore-microtubule attachments and assists spindle forces required for anaphase error correction while delaying nuclear envelope reassembly on lagging chromosomes, independently of microtubule density. We propose that a midzone-based Aurora B phosphorylation gradient actively monitors and corrects frequent chromosome segregation errors to prevent micronuclei formation during human cell division.

1 November 2016 in Cell Reports
Verified
Journal Article
Open access
BOBernard Nunes de Almeida Orr
Bernard Nunes de Almeida Orr
LTLama Talje
Lama Talje
ZLZhexian Liu
Zhexian Liu
BKBenjamin H. Kwok
Benjamin H. Kwok
DCDuane A. Compton
Duane A. Compton
Karyotype diversity is a hallmark of solid tumors that contributes to intratumor heterogeneity. This diversity is generated by persistent chromosome mis-segregation associated with chromosomal instability (CIN). CIN correlates with tumor relapse and is thought to promote drug resistance by creating a vast genomic landscape through which karyotypically unique clones survive lethal drug selection. We explore this proposition using a small molecule (UMK57) that suppresses chromosome mis-segregation in CIN cancer cells by potentiating the activity of the kinesin-13 protein MCAK. Sublethal doses of UMK57 destabilize kinetochore-microtubule (k-MT) attachments during mitosis to increase chromosome segregation fidelity. Surprisingly, chromosome mis-segregation rebounds in UMK57-treated cancer cells within a few days. This rapid relapse is driven by alterations in the Aurora B signaling pathway that hyper-stabilize k-MT attachments and is reversible following UMK57 removal. Thus, cancer cells display adaptive resistance to therapies targeting CIN through rapid and reversible changes to mitotic signaling networks.